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Human herpesvirus 8 (HHV-8) or Kaposi’s sarcoma-associated herpesvirus (KSHV) is the only known human member of
the Rhadinovirus genus of the gammaherpesvirus subfamily. Antibodies against peptides representing portions of the amino-
and carboxyl-termini of HHV-8 gB were produced and used to detect gB expression in Vero cells transfected with the gB
gene, in the HHV-8-harboring cell line, BCBL-1, and in purified virions. Expression of gB was detected in approximately 3%
of uninduced BCBL-1 cells, while up to 30% of the cells expressed gB after 12-O-tetradecanoylphorbol-13-acetate (TPA)
induction of virus replication. Indirect immunofluorescence assays and confocal microscopy showed that gB was distributed
throughout the cytoplasm of BCBL-1 cells and transfected Vero cells. Immunoblot analyses of virion preparations revealed
the presence of full-length as well as two smaller than full-length gB-derived species corresponding to the amino- and
carboxy-terminal portions of gB, respectively. Biochemical analysis of the gB carbohydrate moieties using glycosylation
inhibitors revealed that gB contained N-linked oligosacharides of the high-mannose type, characteristic of precursor
carbohydrate chains added in the endoplasmic reticulum. © 2000 Academic Press
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Glycoprotein B (gB) is one of the most conserved
herpesvirus glycoproteins. It is an essential virion com-
ponent for members of the alpha- and betaherpesvirus
subfamilies. It is thought to function in virion attachment
and virus entry into susceptible cells (Cai et al., 1988;
Cranage et al., 1986; Pereira, 1994; Roizman and Sears,
1996; Spear, 1993a). Epstein-Barr virus (EBV), a gamma-1
herpesvirus (genus Lymphocryptovirus) (Honess, 1984),
and murine gammaherpesvirus 68 (MHV-68), which is a
member of the gamma-2 herpesvirus (genus Rhadinovi-
rus) subfamily, do not incorporate detectable levels of gB
into their virions (Gong and Kieff, 1990; Stewart et al.,
1994). However, bovine herpesvirus 4, also a gamma-2
herpesvirus (Bublot et al., 1992; Lomonte et al., 1997),
incorporates gB to its virion (Lomonte et al., 1997).
Human herpesvirus 8 (HHV-8), or Kaposi’s sarcoma-
associated herpesvirus, is associated with Kaposi’s sar-
coma, primary effusion lymphoma, and multicentric
Castlesman’s disease (Cesarman et al., 1996; Chang et
l., 1994; Said et al., 1996; Soulier et al., 1995). Phyloge-
etic analyses of viral DNA sequences revealed that
HV-8 belongs to the gamma-2 sublineage of the gam-
aherpesvirus subfamily, and thus represents the first
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18uman gamma-2 herpesvirus identified (Moore et al.,
996).
The present study was carried out to determine
hether gB is a component of the HHV-8 virion and
hether certain biochemical properties of HHV-8 gB are
imilar to those reported for other gB homologs. Antibod-
es against peptides representing portions of the amino-
nd carboxyl-termini of HHV-8 gB were produced and
sed to detect gB expression in Vero cells transfected
ith the gB gene, in the HHV-8-harboring lymphoma cell
ine, BCBL-1, and in purified virions. We found that gB is
art of the HHV-8 virion as full-length and cleaved protein
nd shares biochemical characteristics with other gB
omologs.
RESULTS
Expression of HHV-8 gB in Vero cells transfected with
he gB gene and in BCBL-1 cells. To facilitate the detec-
ion of gB, anti-peptide antibodies were produced
gainst synthetic peptides representing immunogenic
ortions of gB. Peptides were coupled to keyhole limpet
emocyanin (KLH) before immunization of rabbits (see
aterials and Methods). To validate the specificity of the
abbit antisera generated against HHV-8 gB peptides,
ero cells were transfected with the pcDNA-gB plasmid
arrying the entire gB gene under the promoter control of
he human cytomegalovirus immediate early promoter,
nd gB expression was detected by IFA at 48 h post-
ransfection. Antibodies gB-N1 and gB-C detected gB in
BL-1 c
magnifi
19HUMAN HERPESVIRUS 8 gBapproximately 5% of the cells, and fluorescent signals
were dispersed throughout their cytoplasm (Fig. 1A, B).
The reactivities of the antibodies were then tested
against BCBL-1 cells. Antibodies gB-N1 and gB-C re-
acted strongly with approximately 3% of uninduced (Fig.
1C, D) and up to 30% of TPA-induced BCBL-1 cells (Fig.
1E, F). Fluorescent signals were distributed throughout
the cytoplasm and perinuclear spaces. No reactivity was
detected in Vero cells transfected with the plasmid vec-
tor alone or with preimmune sera (not shown).
To improve the visualization of gB distribution within
cells, BCBL-1 cells were fixed with paraformaldehyde
and labeled with the gB peptide antibodies as well as
with a nuclear counterstain as described under Materi-
als and Methods and then examined by confocal micros-
copy (Fig. 2). Although paraformaldehyde is sometimes
used to crosslink the surface of cells to prevent antibody
penetration, induced BCBL-1 cells that had been treated
with paraformaldehyde were permeable to antibodies
FIG. 1. Immunofluorescence detection of HHV-8 gB using anti-gB-pep
with methanol at 48 h after transfection (A, B). Indirect immunofluores
antibody (B, D, F). Uninduced BCBL-1 cells (C, D) and TPA-induced BC
treatment. Cells were visualized by fluorescence microscopy at 400Xdirected against nuclear membrane and endoplasmic
reticulum proteins (not shown), thus the reactivity seenhere was not limited to the cell surface. Reactivity with
antibody gB-N1 and gB-N2 was detected in the cyto-
plasm of TPA-induced BCBL-1 cells (Fig. 2, panels 1 and
2, respectively); however, gB-N1 produced a more in-
tense fluorescent signal than the gB-N2 antibody. Anti-
body gB-C reacted strongly with paraformaldehyde-fixed
BCBL-1 cells (Fig. 2, panel 3). Antibodies gB-N1 (Fig. 2,
panel 4), gB-N2, and gB-C (not shown) produced very
weak signals against uninduced cells. In addition, con-
focal microscopy of TPA-induced BCBL-1 cells revealed
cellular structures that contained gB but without any
detectable nuclear material. The largest of these struc-
tures was approximately the size of mononuclear
BCBL-1 cells (Fig. 2, panel 1). These structures may
represent cytosolic portions of cells that blebbed off after
TPA induction.
Synthesis and processing of HHV-8 gB in COS cells
transfected with the gB gene and in BCBL-1 cells. COS
cells were transfected with the gB gene and gB was
tibodies. Vero cells transfected with the pcDNA-gB plasmid were fixed
was performed with the gB-N1 antibody (A, C, E) and with the gB-C
ells (E, F) reacted with gB-N1 (C, E) or gB-C (D, F) at 2 days after TPA
cation.tide an
cencedetected by immunoblot analysis at 48 h posttransfection
in the presence or absence of the N-glycosylation inhib-
e. Indir
es con
20 BAGHIAN ET AL.itor tunicamycin (TM) (Fig. 3). Antibody gB-C reacted with
a 107-kDa protein (Fig. 3A, lane 2). In the presence of TM,
the 107-kDa protein species was not detected, while a
new protein species of approximately 85 kDa appeared
(Fig. 3A, lane 3). For comparison, antibody gB-C reacted
against extracts from purified HHV-8 virions detected
112-, 107-, and 59-kDa proteins (Fig. 3, lane 4).
Similar experiments were performed to detect gB in
uninduced and TPA-induced BCBL-1 cells in the pres-
ence and absence of glycosylation inhibitors (Fig. 3B).
Antibody gB-C reacted with major protein species of
112-, 107-, and 59-kDa in TPA-induced cells (Fig. 3B, lane
2). Proteins of similar sizes were present in substantially
lower amounts in uninduced cells (Fig. 3B, lane 1). The
relative amounts of other protein species did not change
after TPA induction and thus were considered to repre-
sent background reactivity (Fig. 3B, lanes 1 and 2). To
inhibit N-linked glycosylation, TM was added to BCBL-1
cells concurrent with TPA induction, and cells were har-
vested 2 days later. The amounts of the 112-, 107-, and
59-kDa proteins were drastically reduced in the pres-
ence of TM, while a new gB-C-reactive species of ap-
proximately 90 kDa was detected (Fig. 3B, lane 3). The
processing pathway of gB in induced BCBL-1 cells was
FIG. 2. Confocal immunofluorescence detection of gB in BCBL-1 c
induction and mounted onto slides after fixing with 3% paraformaldehyd
Panel 3 shows a representative syncytium structure. Blebbing structurfurther examined using endoglycosidase H (endo-H),
which specifically cleaves high mannose, non-Golgi pro-cessed sugars (Tarentino et al., 1989; Maley et al., 1989).
Digestion by endo-H of extracts from cells induced by
TPA in the absence of TM produced gB species ranging
in molecular mass from 112–90 to 51–46 kDa (Fig. 3B,
lane 4 compared to lane 2). Peptide N-glycosidase F
(PNGase F) is an amidase that cleaves between the
innermost GlcNAc and asparagine residues of high man-
nose, hybrid, and complex oligosacharides from N-linked
glycoproteins (Maley et al., 1989; Tarentino et al., 1990).
Digestion with PNGase F of extracts of BCBL-1 cells
induced by TPA in the absence of TM produced two
major gB-C-reactive species of approximately 98–90 and
46 kDa (Fig. 3B, lane 5).
Detection of gB and gB-related peptides in HHV-8
virions. The gB-C and gB-N1 antibodies were used to
detect gB in purified virion samples obtained from su-
pernatant fluids by differential centrifugation or by puri-
fying virions through density gradients (see Materials
and Methods). Antibody gB-C reacted specifically with
the proteins of 112-, 107-, and 59-kDa apparent molecular
masses in immunoblots of electrophoretically separated
proteins from purified virions obtained from supernatants
(Fig. 3A, lane 4; Fig. 3B lane 6; Fig. 4A, lane 1) as well as
from gradient-purified virions (Fig. 4A, lane 2). The
A-induced and uninduced BCBL-1 cells were harvested 5 days after
ect immunofluorescence was performed with the indicated antibodies.
taining gB have no visible nucleus in panel 1.ells. TPamounts of the 112- and 107-kDa proteins were de-
creased in gradient-purified virion samples in compari-
21HUMAN HERPESVIRUS 8 gBson to the purified virion samples obtained from super-
natant fluids, while a smaller protein of approximately
40-kDa apparent molecular mass was present in virions
obtained from supernatant fluids but not present in den-
sity gradient-purified virion samples (Fig. 4A, lanes 1 and
2). Antibody gB-N1, which reacts with the amino-terminal
portion of gB, detected specifically a 75-kDa protein
species in virion samples purified from either superna-
tant fluids or through density gradients. Decreased
amounts of the 75-kDa protein were detected in gradient-
purified samples in comparison to virion samples ob-
tained from supernatant fluids (Fig. 4B, lanes 1 and 2,
respectively).
The processing pathway of gB in purified virions was
further examined using enzymes endo-H and endo-F.
Antibody gB-C reacted specifically with proteins of 112–
107 and 59 kDa (apparent molecular masses) in immu-
noblots of electrophoretically separated proteins from
FIG. 3. The effect of glycosylation inhibitors on gB expressed in COS
and BCBL-1 cells. (A) COS cells were transfected with the HHV-8 gB
gene-expressing plasmid and incubated in the presence or absence of
TM. Cellular extracts were collected at 48 h posttransfection and tested
for the presence of gB in immunoblots using the gB-C antibody. Lane 1:
mock-transfected COS cells. Lanes 2 and 3: COS cells transfected with
the gB gene in the absence and presence of TM, respectively. Lane 4:
extracts of virions purified from BCBL-1 supernates. The location of the
107-kDa gB species in lane 2 and the location of the gB-doublet of 112-
and 107-kDa species in lane 4 are marked with a solid dot. The location
of the 85-kDa species produced in the presence of TM is marked by an
arrow in lane 3. (B) BCBL-1 cells incubated in the presence of TPA
alone or in the presence of TPA and TM were harvested at 48 h
post-TPA induction. Cellular extracts derived from TPA-induced BCBL-1
cells were treated with either endo-H or PNGase F. Immunoblot anal-
ysis was used to detect gB using antibody gB-C. Lane 1: BCBL-1 cells
in the absence of TPA induction. Lane 2: BCBL-1 cellular extracts after
TPA induction. Lane 3: BCBL-1 cellular extracts after TPA and TM
treatment. Lane 4: sample from TPA-induced cells digested with
endo-H. Lane 5: TPA-induced cellular extracts digested with PNGase F.
Lane 6: virion extracts reacted with anti-gB-C antibody. The location of
the 112-kDa species in lane 6 is marked with a solid dot. The location
of the 59-kDa species in lane 6 is marked with a solid square. The
location of the 90-kDa species produced in the presence of TM is
marked by an arrow in lane 3.purified virions (Fig. 5, lane 4), which exhibited similar
mobilities to gB-C antibody-reactive protein species fromTPA-induced BCBL-1 cells that served as controls (Fig. 5,
lane 3). For comparative purposes, the gB-C antibody
was also reacted against extracts from both BJAB cells
as well as BCBL-1 cells in the absence of TPA induction.
The gB-C antibody did not react with proteins of 112–107
kDa; however, it did react with a protein species of
approximately 57 kDa that was present in samples from
both BJAB and uninduced BCBL-1 cells (Fig. 5, lanes 1, 2).
The fact that the 57-kDa protein was detected in both
BJAB and BCBL-1 cells without TPA induction indicates
that this reaction was nonspecific. Digestion by endo-H
of extracts from purified virions produced gB species
with faster electrophoretic mobilities ranging in apparent
molecular mass of approximately 107–90 and 51–45 kDa
(Fig. 5, lane 5 compared to lane 4). Digestion of purified
virions with PNGase F produced two major gB-C-reactive
species of approximately 95–90 and 45 kDa (Fig. 5, lane
6).
DISCUSSION
We produced specific antibodies against HHV-8 gB
and demonstrated that unlike EBV gB, HHV-8 gB is a
major component of the virion particle. Furthermore, we
demonstrated that gB is incorporated in virions as full-
length and cleaved forms and that it is predominantly
N-glycosylated.
gB homologs specified by varicella zoster virus (VZV),
FIG. 4. Detection of gB in purified virions. Virions were purified from
the supernatant fluids of BCBL-1 cells prepared 2 days after TPA
addition. Purified viral antigens were reacted in immunoblots with gB-C
and gB-N1 antibodies and visualized using chemiluminescence. (A)
Lanes 1 and 2: extracts of virions purified from either supernatant fluids
or density gradients, respectively, reacted with the gB-C antibody. The
location of the 112-kDa gB species is marked with a solid dot and the
59-kDa gB species is marked with an asterisk. (B) Lanes 1 and 2:
extracts of virions purified from either supernatant fluids or density
gradients, respectively, reacted with the gB-N1 antibody. The location of
the 75-kDa gB species in B is marked with an arrowhead. Molecular
mass markers are as shown and are the same for both A and B.
22 BAGHIAN ET AL.human cytomegalovirus, human herpesvirus 6, bovine
herpesvirus 1 (BHV-1), bovine herpesvirus 4 (BHV-4),
pseudorabies virus, Marek’s disease virus, equine her-
pesvirus 1, equine herpesvirus 4 (EHV-4), murine cyto-
megalovirus, and feline herpesvirus 1 are proteolytically
cleaved into two major parts after digestion between the
R and S amino acids of the consensus site RX(R/K)RS
which is located near the middle of the extracellular
domain of the molecule (Pereira, 1994). The cleaved
domains retain their covalent association via disulfide
bonds (Pereira, 1994; Spaete et al., 1988). However,
cleavage of the BHV-1 gB molecule was shown not to be
required for gB function (Kopp et al., 1994). The predicted
primary sequence of HHV-8 gB includes a potential pro-
teolytic cleavage site (RKRR/S) located between amino
acids 440 and 441 of the HHV-8 gB predicted amino acid
sequence. The predicted molecular weight of the amino
acid backbone of HHV-8 gB is 93,978 and 91,307 Da
FIG. 5. The effect of glycosylation inhibitors on gB expressed in
purified virions. (A) Immunoblot analysis was used to detect gB in
samples prepared from cellular extracts and virions purified from su-
pernatant fluids of BCBL-1 cells using antibody gB-C. In addition,
purified virion samples were digested with either endo-H or PNGase F.
Cellular extracts obtained from either BJAB or BCBL-1 cells without TPA
induction were reacted with the gB-C antibody and served as back-
ground controls. Lane 1: BJAB cells. Lane 2: BCBL-1 cells in the
absence of TPA induction. Lane 3: BCBL-1 cellular extracts after TPA
induction. Lane 4: purified virion samples in the absence of any enzy-
matic treatment. Lane 5: purified virions digested with endo-H. Lane 6:
purified virion samples digested with PNGase F. The location of the
112-kDa species in lane 6 is marked with a solid dot. The location of the
59-kDa species in lane 6 is marked with a star. The locations of the
45-kDa gB species produced after either endo-H or PNGase F treat-
ment is marked with an arrowhead, while the 90-kDa gB species is
marked with an asterisk.without its predicted signal sequence (aa 1–26). The
predicted molecular weights of the amino and carboxylterminal portions obtained after proteolytic cleavage are
45,879 and 45,445 Da, respectively, which correspond to
the probable peptide backbones of the 75- and 59-kDa
N-terminal and C-terminal gB species detected in cells
and virions.
Glycosylation inhibition experiments revealed that
HHV-8 gB contains predominantly N-linked carbohy-
drates in agreement with a previous report describing
the gB specified by the closely related BHV-4 (Lomonte
et al., 1997) as well as with HHV-8 gB transiently ex-
pressed in Chinese hamster ovary (CHO) cells (Pertel et
al., 1998). The amino-terminal portion of HHV-8 gB con-
tains 9 potential N-linked glycosylation sites, while the
carboxy-terminal portion contains 6 sites. Therefore, the
59-kDa species detected in immunoblots of antigens
derived from both BCBL-1 cells and purified virions with
the gB-C antibody may be obtained by glycosylation of
the 45-kDa carboxyl-terminal portion of gB. The 75-kDa
species detected in purified virions with the gB-N1 anti-
body most likely represents the glycosylated version of
the 46-kDa amino terminal portion of gB. The 112-, 107-,
and 59-kDa gB species contain N-linked sugars because
their apparent molecular masses were reduced after
endo-H treatment. This conclusion was confirmed by the
TM experiments with BCBL-1 cells in which the 112- and
107-kDa gB species were replaced by a species of 90
kDa. In these experiments, the amount of 59-kDa protein
was reduced drastically in the TM-treated sample, indi-
cating that the potential precursor protein of the 59-kDa
protein may be rapidly degraded in the absence of N-
glycosylation.
In contrast to results obtained by transiently express-
ing gB in CHO cells where it was found that gB was
localized in the rough endoplasmic reticulum (RER) and
perinuclear spaces (Pertel et al., 1998), gB expressed in
BCBL-1 cells as well as in Vero cells was distributed
throughout the cytoplasm. These differences in gB dis-
tribution detected by immunofluorescence assays may
be due to the different cell lines used in these studies,
the relative amounts of gB expressed under different
conditions, or the different antibodies used to detect gB.
In the presence of TM, a 85-kDa protein was detected
in COS cells transfected with the gB gene instead of the
90-kDa gB expressed in the presence of TM in BCBL-1
cells indicating that the nonglycosylated gB precursor
protein may be partially digested in COS cells. Similar
transient expression experiments in CHO cells indicated
that the full-length gB migrated with an apparent molec-
ular mass of approximately 120 kDa, while gB in the
presence of TM was approximately 95 kDa (Pertel et al.,
1998). The discrepancies in molecular masses between
COS, CHO, and BCBL-1 cells for gB and gB-related pep-
tides may be due to differences in the extent of gB
glycosylation by the different cells used in these studies.
It is important to note that under transient expression
conditions, gB is expressed as full-length, while in
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23HUMAN HERPESVIRUS 8 gBBCBL-1 cells is produced as amino- and carboxyl-termi-
nal portions as well as full-length gB. Thus, it seems that
there is a protease that is responsible for cleavage of gB
in BCBL-1 cells.
Apparently, gB exists in virions as a full-length protein
as well as in a cleaved form consisting of a 75-kDa
amino terminal portion and a 59-kDa carboxyl-terminal
portion. Addition of the apparent molecular masses of
these two gB species should produce a full-length gB of
approximately 134 kDa instead of the 112-kDa gB de-
tected by gB-C and gB-N1 antibodies. This discrepancy
between predicted and observed molecular masses for
full-length gB may be due to slower electrophoretic mi-
gration of gB fragments in comparison to the full-length
gB. Double-gradient virions appeared to have less full-
length gB than virions produced from BCBL-1 super-
nates. We considered that this difference between the
two virion preparations may be due to either contaminat-
ing full-length gB in BCBL-1 supernates or partial pro-
cessing of gB after virion purification. However, double-
gradient purification should eliminate any specific pro-
teases, and therefore, it is unlikely that specific cleavage
of gB could be achieved after virus purification. There-
fore, our results are consistent with the hypothesis that
gB is found in HHV-8 virions predominantly as 75- and
59-kDa fragments. Furthermore, the amino-terminal por-
tion of gB does not contain any predicted membrane
spanning amino acid sequences; therefore it is likely to
be retained on virions through association with the gB-
carboxyl-terminal portion.
Addition of protease inhibitors such as phenylmethyl-
sulfone fluoride (PMSF) or a mixture of N-tosyl-L-pheny-
ananine chloromethyl ketone (TPCK) and N-p-tosyl-L-
ysine chloromethyl ketone (TLCK) protease inhibitors
rior and during cellular disruption failed to inhibit pro-
eolytic cleavage of gB, indicating that this activity does
ot occur after lysis due to lysosomal enzymes that are
eleased by cellular disruption (not shown). Transient
xpression of gB in COS cells revealed the presence of
ull-length gB, while the 59-kDa portion of gB detected in
CBL-1 cells was not detected (Fig. 3A). Similar results
ere obtained in experiments in which gB was ex-
ressed in BHK-1 cells under transient conditions using
lasmid-based expression vectors or the Semliki Forest
irus expression System (DiCiommo and Bremner, 1998).
oreover, extracts prepared from uninduced BCBL-1 or
JAB cells, when incubated with gB expressed via tran-
ient expression in COS cells, failed to cleave gB and
roduce the 59-kDa gB species (not shown). Thus, gB
leavage seems to be intimately associated with gB
xpression in BCBL-1 cells.
Amino acid sequences of gB are highly conserved
mong herpesviruses. Furthermore, gB specified by al-
ha- and betaherpesviruses function in virus entry and
irus-induced cell fusion (Pereira, 1994; Spear, 1993a,b).
pparently, these membrane fusion functions of gB areot shared by the EBV gB homolog, because EBV gB is
ot found in EBV virions and is not expressed on the
urface of infected cells, but it is strictly localized on the
ough endoplasmic reticulum and nuclear membranes
Emini et al., 1987; Gong et al., 1987; Gong and Kieff,
990; Qualtiere and Pearson, 1979). In contrast, both
HV-4 (Lomonte et al., 1997) and HHV-8 contain gB in
heir virions, and HHV-8 expresses gB throughout the
ytoplasm of BCBL-1 cells. The presence of gB in HHV-8
irions suggests that it may function in virion entry.
MATERIALS AND METHODS
Cells and virus purification. BJAB cells were obtained
rom Naoki Inoye (Centers for Disease Control and Pre-
ention, Atlanta, GA). BCBL-1 cells (Renne et al., 1996)
ere obtained from the NIH AIDS Reference and Re-
gent Program and cultured according to the instructions
rovided. The lytic cycle was induced by treatment with
0 ng/ml of the phorbol ester, 12-O-tetradecanoylphor-
ol-13-acetate (Sigma Chemical Corp., St. Louis, MO).
ero cells were grown in Dulbecco’s modification of
agle’s medium supplemented with 7% heat-inactivated
etal calf serum and penicillin and streptomycin. For virus
urifications, 5 liters of induced BCBL-1 cell superna-
ants was harvested at 8 days postinduction (d.p.i.) and
iltered through a 0.45-mm filter and then virions were
pelleted at 22,000 g for 16 h. Virion pellets were allowed
to resuspend overnight on ice in TNE buffer (0.1 M Tris,
pH 7.4, 0.1 M NaCl, 0.001 M EDTA) containing protease
inhibitors. Pellets were pooled and layered onto a 20–
35% Accudenz (Accurate Chemical Corp., Westbury, NY)
step gradient and then centrifuged at 82,500 g in a
swinging bucket rotor for 2 h at 5°C. The band visible at
the interface was collected, diluted with cold TNE,
layered onto a 15–50% continuous Accudenz gradient,
and centrifuged as described above. A single-wide band
of 1.5 ml was collected, diluted with TNE, layered onto a
second 15–50% continuous Accudenz gradient, and cen-
trifuged under identical conditions. The final band was
collected and diluted in 10 ml of Tris-buffered saline
(TBS), and then virions were pelleted at 77,000 g in a
swinging bucket rotor for 1 h at 5°C. Electron micro-
scopic examination of purified virions revealed a high
concentration of apparently intact virions and very little
visible cellular debris.
Alternatively, viruses were partially purified by sepa-
rately harvesting cells and supernatants obtained from
two 250-ml cell cultures. Supernatant fluids were centri-
fuged at 1500 g to remove any cells and kept in ice. Cells
were collected by centrifugation, suspended into 10 ml of
PBS buffer, freeze-thawed three times, and subsequently
centrifuged at 1500 g in a preparative centrifuge for 15
min. Supernates from these preparations were combined
with clarified supernates from the original cell cultures.
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24 BAGHIAN ET AL.These fluids were cleared by centrifugation at 5000 g for
30 min and passed through a 0.2-mm filter. Filtered viri-
ons were pelleted at 27,000 g for 3 h and then viral
pellets were resuspended in 40 ml of phosphate-buff-
ered saline (PBS) and repelleted as above. Pellets were
resuspended in 200–300 ml of PBS before processing for
DS-PAGE. Electron microscopic examination showed
hat these preparations contained high concentrations of
irions and low amounts of cellular debris (not shown).
Plasmid construction (pcDNA-gB). HHV-8 glycoprotein
was amplified by PCR from BCBL-1 cells with primers
9-GGAATTCCGCTAGCTGGGTATTTAAGGACCTGTAC
nd 59-CGGGATCCAAGCTTAGAGGCGGGCCGT GTTTC-
TA based on the BCBL-1 gB DNA sequence (Meng et
l., in press). The resulting PCR product, which contains
9 bp of the 59 nontranslated sequence, the entire open-
eading frame, and the stop codon, was cloned into
cDNA 3.1/Zeo (1) (Invitrogen, Inc., Carlsbad, CA) using
he unique restriction sites NheI and BamHI, yielding the
ecombinant plasmid pcDNA-gB. The ends of the cloned
B DNA fragment were sequenced using the T7-forward
nd pcDNA3.1/BGH-reverse primers (Invitrogen, Inc.) to
onfirm that gB was correctly inserted for expression.
sCl2-purified plasmid DNA was used for transient ex-
ression experiments.
Peptide synthesis and immunizations. Peptides repre-
enting three regions of the predicted translation product
f the HHV-8 gB gene were synthesized using an auto-
ated peptide synthesizer (Model 432A, Applied Biosys-
ems, Foster City, CA) according to the manufacturers
nstructions. Peptide gB2575 (gB-N1) contained aa 27–
2, peptide gB2518 (gB-N2) contained aa 167 to 191, and
eptide gB2523 (gB-C) contained aa 828 to 845. Syn-
hetic peptides were coupled to keyhole limpet hemocy-
nin, emulsified with Freund’s complete adjuvant for the
rimary immunization and Freund’s incomplete adjuvant
or two booster immunizations. Two New Zealand white
abbits per peptide were immunized subcutaneously
ith each conjugated peptide.
Transfection and immunofluorescence assays. Vero
ells were seeded in 24-well plates on glass coverslips.
hen cells reached 50–60% confluency, they were trans-
ected with the plasmid pcDNA-gB using Lipofectamine
eagent according to the manufacturer’s instructions
Life Technologies, Gaithersburg, MD). Transfected cells
ere incubated for 48 h at 37°C, and then coverslips
ere fixed with methanol for 20 min, rinsed three times
ith PBS, and then processed for immunofluorescence
taining. Rabbit antisera to gB peptides (see below) were
sed in IFA at a dilution of 1:100 in 10% normal goat
erum in PBS. BCBL-1 cells were centrifuged onto a slide
sing a cytospin centrifuge and processed as detailed
bove for the gB gene-transfected Vero cells. Fluores-
ein-conjugated goat anti-rabbit antibody (ICN Pharma-
euticals, Inc., Aurora, OH) was used as the secondary
ntibody.Confocal microscopy. Cytospin-prepared cells were
ixed in paraformaldehyde (3% in PBS) and then incu-
ated with the indicated antiserum for 1 h at 4°C fol-
owed by washing three times with ice-cold PBS. Incu-
ation with the secondary antibody, Oregon Green 488-
onjugated goat anti-rabbit IgG (Molecular Probes, Inc.,
ugene, OR) at a 1:200 dilution in 20% horse serum in
BS) was used at 4°C for 1 h. Microscopic examination
as with a Zeiss LSM 410 inverted confocal microscope
quipped with an argon/krypton laser and a 40X (1.2
.A.) objective using the appropriate excitation and
mission filters.
Immunoblot analysis. Cell lysates or purified virions
ere diluted in loading buffer (2% SDS, 1% 2-mercapto-
thanol, 10% glycerol, and 0.001% bromphenol blue in
.5 M Tris-HCl, pH 6.8) and separated by SDS-PAGE
Laemmli, 1970) in 10% polyacrylamide gels. Proteins
ere electrotransferred onto nitrocellulose membranes,
locked with BLOTTO (5% nonfat milk in 0.01 M PBS/
.05% Tween 20), and then reacted 1 h with the indicated
B peptide antiserum at a dilution of 1:400 at room
emperature. Membranes were washed three times with
he same buffer and proteins were visualized by either
lkaline phosphatase or chemiluminescence (Alkaline
hosphatase Conjugate Substrate Kit, Bio-Rad, Inc., Her-
ules, CA; SuperSignal Substrate Western blotting
hemiluminescence detection kit, Pierce, Inc., Rockford,
L).
Glycosylation studies. Tunicamycin was purchased
rom Boehringer Mannheim Corp. (Indianapolis, IN). En-
oglycosidase H and peptide endoglycosidase F (PN-
ase F) were purchased from New England BioLabs
Beverly, MA). Approximately, 106 BCBL-1 cells were ob-
tained from cell cultures grown in the presence or ab-
sence of TPA for 48 h. Other BCBL-1 cell cultures were
incubated in the presence of TM (1 mg/ml) added simul-
aneously with TPA. Cells were collected by low-speed
entrifugation (5 min at 500 g), washed by resuspending
nd pelleting in PBS, and then lysed in 750 ml of double-
distilled water. Cellular extracts were sonicated for 7 s
(Sonifier Cell Disruptor 200, Branson, Inc., Danbury, CT)
and centrifuged (5 min at 1000 g), and then supernatants
were collected. Endo-H and PNGase-F digestions were
performed on 100 ml of cellular extracts using 1000 U of
each enzyme per reaction for 1 h at 37°C, and otherwise
according to the manufacturer’s instructions (New En-
gland BioLabs). Enzyme reactions were stopped by the
addition of loading buffer to samples for SDS-PAGE anal-
ysis.
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